期刊文献+

犬小孢子菌微量液基稀释法抗真菌药敏试验的方法学研究 被引量:5

Research about the Broth Microdilution Antifungal Susceptibility Testing Condition for 182 Microsporum Canis
下载PDF
导出
摘要 目的对北京儿童医院的头癣患者分离所得的182株犬小孢子菌进行抗真菌药敏试验条件的探索。方法对致病真菌进行取样、培养、鉴定、分离和纯化,经微量稀释法测定8种常见抗真菌药物的最小抑菌浓度,并对原药敏方案进行适当调整。结果受试菌株的接种浓度为1—3×10^4 CFU/mL。除伊曲康唑、联苯苄唑、阿莫罗芬外,使用沙氏液体培养基测定的药物最小抑菌浓度均较使用RPMI-1640液体培养基时药物浓度明显升高。孵育温度为28℃,孵育时间为5d。结论各种药物的最小抑菌浓度(minimal inhibitory concentration,MIC)之间的差异有统计学意义,M38-A方案有较好的重复性和稳定性,可作为一种较好的实验室方法被应用。 Objective Study on the broth microdilution antifungal susceptibility testing condition about 182 Microsporum canis derived from patients in Beijing Children' s Hospital. Methods The vitro method was used for testing filamentous fungi. We approached the broth microdilution antifungal susceptibility testing condition for Microsporum canis and tested the minimal inhibitory concentration (MIC) of 8 common antifungal drugs. Results The broth microdilution antifungal susceptibility testing condition for Microsporum canis : inoculum size ranged from 1 × 10^4 to 3 × 10^4 CFU/mL; MICs obtained from different medium at the same incubation time for the same isolate were significantly different, MICs were consistently higher with SDB than with RPMI-1640, when itraconazole, bifonazole, amorolfine were tested, no parameter had any influence on MICs ; incubation temperature was 28 ℃, Microsporum canis produced clearly detectable growth after 5 d. Conclusion With good reproducibility and feasibility, the M38-A procedure can be used for the antifungal susceptibility test to dermaphytes in the laboratories.
出处 《首都医科大学学报》 CAS 2006年第6期750-753,共4页 Journal of Capital Medical University
关键词 犬小孢子菌 药敏试验 M38-A方案 Microsporum canis susceptibility test M38-A procedure
  • 相关文献

参考文献9

  • 1Butty P,Lebecq J C,Mallie M,et al.Evaluation of the susceptibility of dermatophytes to antifungal drugs:a new technique[J].J Med Vet Mycol,1995,33:403-409.
  • 2Fernandez-Torres B,Inza I,Guarro J.Comparison of in vitro antifungal susceptibilities of conidia and hyphae of dermatophytes with thick-wall macroconidia[J].Antimicrob Agents Chemother,2003,47:3371-3372.
  • 3Fernandez-Torres B,Cabanes F J,Carrillo-Munoz A J,et al.Collaborative evaluation of optimal antifungal susceptibility testing conditions for dermatophytes[J].J Clin Microbiol,2002,40:3999-4003.
  • 4Jessup C J,Warner J,Isham N,et al.Antifungal susceptibility testing of dermatophytes:establishing a medium for inducing conidial growth and evaluation of susceptibility of clinical isolates[J].J Clin Microbiol,2000,38:341-344.
  • 5Santos DA,Hamdan JS.Evaluation of broth microdilution antifungal susceptibility testing conditions for trichophyton rubrum[J].J Clin Microbiol,2005,43:1917-1920.
  • 6Provine H,Hadley S.Preliminary evaluation of a semisolid agar antifungal susceptibility test for yeasts and molds[J].J Clin Microbiol,2000,38:537-541.
  • 7Ghannoum M A,Chaturvedi V,Espinel-Ingroff A,et al.Intra-and interlaboratory study of a method for testing the antifungal susceptibilities of dermatophytes[J].J Clin Microbiol,2004,42:2977-2979.
  • 8Nimura K,Niwano Y,Ishiduka S,et al.Comparison of in vitro antifungal activities of topical antimycotics launched in 1990s in Japan[J].Int J Antimicrob Agents,2001,18:173-178.
  • 9Chadeganipour M,Nilipour S,Havaei A.In vitro evaluation of griseofulvin against clinical isolates of dermatophytes from Isfahan[J].Mycoses,2004,47:503-507.

同被引文献55

引证文献5

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部